The topic of biologic therapy for IBD has been selected for this Focus ... or biologic agents once corticosteroids are indicated, to induce clinical remissions. Factors such as extensive disease ...

More clinical trials need to be carried out in order to find new agents as routine treatments for IBD patients. Considering the efficacy, indication and side effects of biological agents ...

Women aged 18 to 45 years with IBD were invited to complete a survey regarding knowledge, attitude, and beliefs about contraception.

On this day Dr. Wolf is seeing his patient Katie for her Crohn's disease— a type of IBD that can affect the entire digestive tract but is most prevalent in the ...

Ulcerative colitis in children is often characterized by extensive colitis with a cumulative rate of colectomy up to 40% at 10 years. Scheduled combination therapy with anti-TNF (and pretreatment ...

upfront for rights to an anti-TL1A therapy being developed by Teva for inflammatory bowel disease, joining a race to bring the first drug in the class to market. Sanofi has acquired rights to co ...

Mesoblast has gained US Food and Drug Administration (FDA) approval for its mesenchymal stromal cell (MSC) therapy ... and biologic-resistant inflammatory bowel disease. Other therapies, such ...

About SOR102 SOR102, an oral biologic, simultaneously inhibits TNF⍺ and IL-23(p19), two clinically validated drivers of inflammatory bowel disease (IBD), providing combination therapy locally ...

So we have many different medications that work to treat ulcerative colitis. We break them down into different categories and also for different indications ... would be our biologic agents.